drugset / Trial / NCT00525941

An Exploratory Study of NBI-34060 Capsules and Next Day Functioning

NCT00525941

Phase 3 Withdrawn Neurocrine Biosciences
Non-randomizedSingle-groupSingle-blindTreatment

Summary

NBI-34060 is an investigational (research) medication being studied in people with insomnia. The current study is designed to evaluate how people, who experience a nighttime awakening with difficulty returning to sleep, feel during the next day after dosing with NBI-34060. The study will also examine the pattern and extent of nighttime awakenings as reported by the patients, as well as and the patient's sleep experience during treatment.

Timeline

Start
2007-09
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Indiplon Small molecule 10 mg

Indications